{"id":"https://openalex.org/W2018669447","doi":"https://doi.org/10.1016/j.jalz.2008.05.666","title":"P1\u2010080: Ask1 kinase\u2010dead knock\u2010in mice and models of neurodegeneration","display_name":"P1\u2010080: Ask1 kinase\u2010dead knock\u2010in mice and models of neurodegeneration","alternate_titles":[],"publication_year":2008,"publication_date":"2008-07-01","ids":{"openalex":"https://openalex.org/W2018669447","doi":"https://doi.org/10.1016/j.jalz.2008.05.666","mag":"2018669447"},"language":"en","primary_location":{"id":"doi:10.1016/j.jalz.2008.05.666","doi":"https://doi.org/10.1016/j.jalz.2008.05.666","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2008.05.666","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's &amp; Dementia","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2018669447"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110107318","display_name":"Karen L. Philpott","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Karen L. Philpott","raw_affiliation_strings":["GlaxoSmithKline, Harlow, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Harlow, United Kingdom","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040563469","display_name":"Kim T. Brackenborough","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kim Brackenborough","raw_affiliation_strings":["GlaxoSmithKline, Harlow, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Harlow, United Kingdom","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006221519","display_name":"Stephen D. Skaper","orcid":"https://orcid.org/0000-0001-5012-9660","observed_orcids":["https://orcid.org/0000-0001-5012-9660"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stephen D. Skaper","raw_affiliation_strings":["GlaxoSmithKline, Harlow, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Harlow, United Kingdom","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049913326","display_name":"Claire I. Hobbs","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Claire I. Hobbs","raw_affiliation_strings":["GlaxoSmithKline, Harlow, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Harlow, United Kingdom","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110170591","display_name":"Christopher J. Hille","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christopher Hille","raw_affiliation_strings":["GlaxoSmithKline, Harlow, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Harlow, United Kingdom","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073182160","display_name":"Ryan P. Bingham","orcid":"https://orcid.org/0000-0001-7990-224X","observed_orcids":["https://orcid.org/0000-0001-7990-224X"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ryan Bingham","raw_affiliation_strings":["GlaxoSmithKline, Harlow, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Harlow, United Kingdom","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081339338","display_name":"Laura Facci","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Laura Facci","raw_affiliation_strings":["GlaxoSmithKline, Harlow, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Harlow, United Kingdom","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077708941","display_name":"Helen Chapman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Helen Chapman","raw_affiliation_strings":["GlaxoSmithKline, Harlow, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Harlow, United Kingdom","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039213849","display_name":"David R Howlett","orcid":"https://orcid.org/0000-0003-4532-7990","observed_orcids":["https://orcid.org/0000-0003-4532-7990"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David Howlett","raw_affiliation_strings":["GlaxoSmithKline, Harlow, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Harlow, United Kingdom","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035012124","display_name":"Anthony Shillings","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anthony Shillings","raw_affiliation_strings":["GlaxoSmithKline, Harlow, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Harlow, United Kingdom","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062777125","display_name":"Jill C. Richardson","orcid":"https://orcid.org/0000-0001-6564-3187","observed_orcids":["https://orcid.org/0000-0001-6564-3187"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jill C. Richardson","raw_affiliation_strings":["GlaxoSmithKline, Harlow, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Harlow, United Kingdom","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111597095","display_name":"Janet Brownlees","orcid":"https://orcid.org/0000-0002-7035-5160","observed_orcids":["https://orcid.org/0000-0002-7035-5160"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Janet Brownlees","raw_affiliation_strings":["GlaxoSmithKline, Harlow, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Harlow, United Kingdom","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059684091","display_name":"Graham Duddy","orcid":"https://orcid.org/0009-0006-7834-7962","observed_orcids":["https://orcid.org/0009-0006-7834-7962"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Graham Duddy","raw_affiliation_strings":["GlaxoSmithKline, Harlow, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Harlow, United Kingdom","institution_ids":["https://openalex.org/I188950975"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5110107318"],"corresponding_institution_ids":["https://openalex.org/I188950975"],"apc_list":{"value":4200,"currency":"USD","value_usd":4200},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"4","issue":"4S_Part_7","first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.5659000277519226,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.5659000277519226,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11266","display_name":"Neuroinflammation and Neurodegeneration Mechanisms","score":0.11079999804496765,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.047200001776218414,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[],"concepts":[{"id":"https://openalex.org/C124160383","wikidata":"https://www.wikidata.org/wiki/Q14914383","display_name":"ASK1","level":5,"score":0.7417030334472656},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.5912238955497742},{"id":"https://openalex.org/C2776925932","wikidata":"https://www.wikidata.org/wiki/Q1755122","display_name":"Neurodegeneration","level":3,"score":0.4895716607570648},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.4758707880973816},{"id":"https://openalex.org/C2778674702","wikidata":"https://www.wikidata.org/wiki/Q239816","display_name":"MPTP","level":4,"score":0.4630577266216278},{"id":"https://openalex.org/C51551487","wikidata":"https://www.wikidata.org/wiki/Q2043632","display_name":"p38 mitogen-activated protein kinases","level":4,"score":0.45950931310653687},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.45474785566329956},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4533863961696625},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.4512906074523926},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4040127396583557},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.3986864984035492},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.26891854405403137},{"id":"https://openalex.org/C90934575","wikidata":"https://www.wikidata.org/wiki/Q6593810","display_name":"Mitogen-activated protein kinase kinase","level":4,"score":0.2099590301513672},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.20115205645561218},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.19068163633346558},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1702641248703003},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0756608247756958},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.054770827293395996},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jalz.2008.05.666","doi":"https://doi.org/10.1016/j.jalz.2008.05.666","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2008.05.666","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's &amp; Dementia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1990718388","https://openalex.org/W773383179","https://openalex.org/W2975003895","https://openalex.org/W2107835713","https://openalex.org/W2204172854","https://openalex.org/W2770340841","https://openalex.org/W1991505929","https://openalex.org/W2781592358","https://openalex.org/W3128333234","https://openalex.org/W2153794304"],"abstract_inverted_index":{"ASK1":[0,37,60,88,112,114,176,182,207,237,244,247,274,295],"kinase":[1,89,124],"lies":[2],"upstream":[3],"of":[4,15,30,74,78,101,109,215,307,331],"p38":[5,191],"and":[6,9,20,70,144,157,310],"JNK":[7],"kinases":[8],"is":[10,61],"activated":[11,66],"via":[12,175],"a":[13,28,55,79,102,110,188,227,284,305,314],"number":[14,29],"stimuli,":[16],"including":[17],"oxidative":[18,323],"stress":[19,324],"proinflammatory":[21],"agents":[22],"(e.g.":[23],"TNF\u03b1),":[24],"proposing":[25],"involvement":[26],"in":[27,57,67,68,71,122,129,179,190,230,267,273,319,329],"disease":[31],"states.":[32],"Cortical":[33],"neurons":[34,133,203],"cultured":[35,204],"from":[36,136,181,205,236,242,294,301],"knock-out":[38],"(KO)":[39],"mice":[40,115,211,249,276,297],"are":[41],"claimed":[42],"to":[43,64,85,240,259,278],"show":[44,291],"attenuated":[45,272],"neuronal":[46],"cell":[47,216,308],"death":[48,217],"following":[49,171,193],"incubation":[50],"with":[51,141,154,220,251,313,321],"A\u03b225\u201335":[52],"peptide,":[53],"suggesting":[54,283],"role":[56],"Alzheimer's":[58],"disease.":[59,76,333],"reported":[62],"also":[63],"be":[65],"vitro":[69,130],"vivo":[72,320],"models":[73],"Parkinson's":[75,332],"Introduction":[77],"point":[80,120],"mutation":[81,121],"has":[82],"allowed":[83],"us":[84],"generate":[86],"an":[87,148,195,322],"dead":[90],"knock-in":[91],"(KI)":[92],"mouse":[93],"model":[94,330],"which":[95],"more":[96],"accurately":[97],"mimics":[98],"the":[99,107,123,243],"effects":[100],"small":[103],"molecule":[104],"inhibitor,":[105],"i.e.":[106],"presence":[108],"kinase-inactive":[111],"protein.":[113],"were":[116,134,152,271],"generated":[117],"containing":[118],"as":[119,185,304,328],"active":[125],"site":[126],"(K716R).":[127],"For":[128],"analysis,":[131],"cortical":[132,202],"isolated":[135],"E15":[137],"embryos,":[138],"cells":[139,234,293],"treated":[140,153,250],"A\u03b21\u201342":[142,221],"peptide":[143],"toxicity":[145],"measured":[146,166],"using":[147,167],"LDH":[149],"assay.":[150],"Animals":[151],"10\u201330mg/kg":[155],"MPTP":[156,172,252,264],"beam":[158],"walking":[159],"behaviour":[160],"assessed.":[161],"Striatal":[162],"catecholamine":[163,269],"content":[164,270],"was":[165,177],"HPLC":[168],"7":[169],"days":[170],"treatment.":[173],"Signalling":[174],"reduced":[178,255,315],"astrocytes":[180],"KI":[183,208,245,248,275,296],"mice,":[184,282],"evidenced":[186],"by":[187],"reduction":[189],"activation":[192],"either":[194,206],"H2O2":[196],"or":[197,209],"LPS":[198],"stimulus.":[199],"However,":[200],"primary":[201],"wild-type":[210,260,302],"displayed":[212],"similar":[213],"extents":[214],"when":[218,317],"incubated":[219],"peptide.":[222],"Our":[223],"results":[224,290],"thus":[225],"demonstrate":[226],"clear":[228],"difference":[229],"cellular":[231],"responses":[232],"between":[233],"taken":[235],"KO":[238],"compared":[239,258,277],"those":[241],"mice.":[246],"showed":[253],"significantly":[254],"behavioural":[256],"deficits":[257],"animals.":[261],"In":[262,287],"addition,":[263],"induced":[265],"reductions":[266],"striatal":[268],"wild":[279],"type":[280,309],"control":[281],"neuroprotective":[285],"phenotype.":[286],"conclusion":[288],"our":[289],"that":[292],"display":[298],"biochemical":[299],"differences":[300],"cells,":[303],"function":[306],"stimulus,":[311],"together":[312],"phenotype":[316],"challenged":[318],"agent":[325],"commonly":[326],"used":[327]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2018669447","counts_by_year":[{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}
